248 related articles for article (PubMed ID: 21238657)
21. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).
Ekema G; Falchetti D; Boroni G; Tanca AR; Altana C; Righetti L; Ridella M; Gambarotti M; Berchich L
J Pediatr Surg; 2008 Jun; 43(6):1191-5. PubMed ID: 18558205
[TBL] [Abstract][Full Text] [Related]
22. Total parenteral nutrition in patients with short bowel syndrome.
Ekema G; Milianti S; Boroni G
Minerva Pediatr; 2009 Jun; 61(3):283-91. PubMed ID: 19461572
[TBL] [Abstract][Full Text] [Related]
23. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
Cober MP; Teitelbaum DH
Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
[TBL] [Abstract][Full Text] [Related]
24. Effects of fish oil on inflammatory modulation in surgical intensive care unit patients.
Han YY; Lai SL; Ko WJ; Chou CH; Lai HS
Nutr Clin Pract; 2012 Feb; 27(1):91-8. PubMed ID: 22227725
[TBL] [Abstract][Full Text] [Related]
25. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
Koletzko B; Goulet O
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):321-6. PubMed ID: 20393276
[TBL] [Abstract][Full Text] [Related]
26. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
Venick RS; Calkins K
Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
[TBL] [Abstract][Full Text] [Related]
27. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
Burns DL; Gill BM
JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
[TBL] [Abstract][Full Text] [Related]
28. Fish oil emulsions in the management of intestinal failure-associated liver disease.
Mercer DF
J Clin Gastroenterol; 2012; 46(10):823-7. PubMed ID: 23060217
[TBL] [Abstract][Full Text] [Related]
29. Fish oil lipid emulsions and immune response: what clinicians need to know.
Waitzberg DL; Torrinhas RS
Nutr Clin Pract; 2009; 24(4):487-99. PubMed ID: 19605803
[TBL] [Abstract][Full Text] [Related]
30. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.
Xu Z; Li Y; Wang J; Wu B; Li J
Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955
[TBL] [Abstract][Full Text] [Related]
31. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
de Meijer VE; Gura KM; Le HD; Meisel JA; Puder M
JPEN J Parenter Enteral Nutr; 2009; 33(5):541-7. PubMed ID: 19571170
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
[TBL] [Abstract][Full Text] [Related]
33. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease.
Le HD; de Meijer VE; Zurakowski D; Meisel JA; Gura KM; Puder M
JPEN J Parenter Enteral Nutr; 2010; 34(5):477-84. PubMed ID: 20852175
[TBL] [Abstract][Full Text] [Related]
34. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome.
Strang BJ; Reddix BA; Wolk RA
Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 lipids for intestinal failure associated liver disease.
Diamond IR; Pencharz PB; Wales PW
Semin Pediatr Surg; 2009 Nov; 18(4):239-45. PubMed ID: 19782305
[TBL] [Abstract][Full Text] [Related]
36. Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease.
Fuchs J; Fallon EM; Gura KM; Puder M
J Pediatr Surg; 2011 Dec; 46(12):2376-82. PubMed ID: 22152886
[TBL] [Abstract][Full Text] [Related]
37. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial.
Nehra D; Fallon EM; Potemkin AK; Voss SD; Mitchell PD; Valim C; Belfort MB; Bellinger DC; Duggan C; Gura KM; Puder M
JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):693-701. PubMed ID: 23770843
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition.
Tomsits E; Pataki M; Tölgyesi A; Fekete G; Rischak K; Szollár L
J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):514-21. PubMed ID: 20531018
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of short bowel syndrome requiring long-term/home intravenous nutrition compared in children with gastroschisis and those with volvulus.
Sala D; Chomto S; Hill S
Transplant Proc; 2010; 42(1):5-8. PubMed ID: 20172269
[TBL] [Abstract][Full Text] [Related]
40. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure.
Soden JS; Lovell MA; Brown K; Partrick DA; Sokol RJ
J Pediatr; 2010 Feb; 156(2):327-31. PubMed ID: 20105644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
